Stay updated on ELAD Safety and Efficacy in AILD Clinical Trial
Sign up to get notified when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.

Latest updates to the ELAD Safety and Efficacy in AILD Clinical Trial page
- Check4 days agoChange DetectedAdded the Locations section with numerous study sites (Arkansas, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Virginia, Wisconsin, Styria, Bavaria, Madrid, England, Scotland) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure section and older location entries.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page removed a general government funding/status notice; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedNo additions or deletions were observed on the page compared with the previous screenshot.SummaryDifference0.2%

- Check83 days agoChange DetectedAdded a government operations notice with current status and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check90 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

Stay in the know with updates to ELAD Safety and Efficacy in AILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.